"
Team:UNIPV-Pavia/Project/Solution
From 2009.igem.org
(→SYSTEM OVERVIEW) |
(→SYSTEM OVERVIEW) |
||
| Line 188: | Line 188: | ||
Used BioBrick parts: | Used BioBrick parts: | ||
| - | *pdc: codon-optimized coding sequence from Mr Gene de novo synthesis service | + | *pdc (<partinfo>BBa_K173016</partinfo>): codon-optimized coding sequence from Mr Gene de novo synthesis service |
| - | *adhB: codon-optimized coding sequence from Mr Gene de novo synthesis service | + | *adhB (<partinfo>BBa_K173017</partinfo>): codon-optimized coding sequence from Mr Gene de novo synthesis service |
| - | *<partinfo>BBa_B0030</partinfo> - | + | *<partinfo>BBa_B0030</partinfo> - pSB1A2: RBS with efficiency 0.6 |
*<partinfo>B0015</partinfo> - pSB1AK3: Double terminator | *<partinfo>B0015</partinfo> - pSB1AK3: Double terminator | ||
*A promoter to be chosen | *A promoter to be chosen | ||
Revision as of 00:07, 22 October 2009
|
|
|
Solution |
|||||
|
Our aim is to merge and optimize the main features of naturally occurring lactose-cleaving and ethanol-producing microorganisms to build up an engineered biological system that can metabolize lactose and can ferment it in ethanol with high yield. Here we provide an overview of the main enzymes and biochemical pathways involved in these two processes. MICROBIAL SOURCES OF LACTOSEThe complete lactose to ethanol transformation pathway is summarized in the following figure.
The first task of conversion is provided by β-D-Galactosidase. It can be obtained from a wide variety of sources such as microorganisms, plants and animals; however, according to its source, its properties differ markedly.
The products of lactose hydrolysis may inhibit β-galactosidase action. Galactose is often a competitive inhibitor but glucose is usually ineffective, except at higher concentrations when it is usually non-competitive. Complete hydrolysis is therefore very difficult to achieve unless high concentrations of the enzyme are used. Yeast enzymes are generally inhibited by galactose (competitively) and glucose (non-competitively). Aspergillus niger enzyme is strongly inhibited by galactose; however, enzyme from A. oryzae is less subject to galactose inhibition.
These enzymes have a pH optimum in the acidic range 2.5–5.4, which makes them suitable for processing of acid whey and its ultrafiltration permeate. These have a relatively high temperature optimum and are typically used at temperatures up to 50°C, where they are reasonably stable. The production and purification of β-D-galactosidase from different fungal sources have been carried out using a variety of purification techniques. Fungal sources are: Aspergillus niger, Beauveria bassiana, Aspergillus fonsecaeus, Rhizomucor sp., Penicillium chrysogenum, Aspergillus carbonarius.
Yeast has been considered an important source of β-D-galactosidase from an industrial viewpoint. Yeast sources are: Kluyveromyces fragilis, Kluyveromyces lactis, Saccharomyces lactis, Saccharomyces anamensis, Kluyveromyces marxianus, recombinant yeast Saccharomyces cerevisiae.
A large number of bacteria produce β-D-galactosidase, but relatively few bacterial species are regarded as safe sources. However, Streptococcus thermophilus and Bacillus stearothermophilus can be considered as potential bacterial sources. The former is eminently suitable as a source organism from the safety viewpoint because it is used as a starter culture in yoghurt and some cheeses. Other bacterial sources are: Escherichia coli, Propionibacterium shermanii, Streptococcus salivarius, Pseudoalteromonas sp., S. thermophilus, Thermoanaerobacter, Bacillus coagulans, Lactobacillus delbrueckii subsp. Bulgaricus.
It is a tetrameric hydrolytic enzyme, coded by the LacZ gene and able to catalyse the hydrolysis of a disaccharide (β-galacotisedes) into two monosaccharides: it is, then, related to the reaction that injects new glucose into glycolysis. The E. coli isoform is 464K-Da weight and 1021 amino acid long. Each monomer is composed by five domains, the third of which hosts the active site. The protein can be split into two peptides, which are unable to catalyse reaction when separated. This peculiarity gives β.galactosidase a primary importance in synthetic and molecular biology, for it is used as a reporter gene, by fusing protein into the β-gal chain, disrupting the first peptide’s sequence, in a test known as “blue white screening”. A well known galactose homologue, X-Gal, turns blue when hydrolysed by this enzyme and shows whether colonies have incorporated the fusion genes or not. The active site is associated to Glu-537, that is the main actor of a nucleophil substitution between the carboxyl group of the side chain of Glu and the ketonic oxygen that links the two mono-saccharides. Result of this reaction is the substitution of an alcoholic group to the ketonic group and the following liberation of the other monosaccharide. Thus β-gal is the gateway for glucose into the glycolytic process.
ENGINEERING FERMENTATION USING Z. MOBILIS METABOLISM
Zymomonas mobilis is a Gram-negative bacteria of the soil that has several appealing features for its use in the industrial production of ethanol. Zymomonas is the only known microorganism capable of oxidizing glucose anaerobically, via the Entner-Doudoroff pathway, as opposed to the classical glicolytic pathway. Unfortunately Zymomonas can only catabolize simple sugars as glucose, fructose and sucrose. Since our project relies on lactose catabolism, we decided to insert two Zymomonas key fermenting enzymes: the Pyruvate Decarboxylase (pdc) and the Alcohol Dehydrogenase II (adhB) in E. coli, which is, instead, capable of fermenting lactose. E. coli does not possess a native Pyruvate Decarboxylase: although, it uses Pyruvate Formate Lyase. This enzyme has an unbalanced consumption of NADH, and the microorganism balances it by producing acetic acid and succinic acid rather than ethanol. The insertion of Zymomonas pdc gene should determine the production of ethanol as only final product of the fermentation pathway. Although E. coli strains have Alcohol Dehydrogenase, the activity of this native enzyme is insufficient to achieve this high yield of ethanol, while Zymomonas adhB enzyme has a higher efficiency.
Pyruvate decarboxylase is a homotetrameric enzyme (EC 4.1.1.1) that catalyses the decarboxylation of pyruvic acid to acetaldehyde and carbon dioxide. It is also called 2-oxo-acid carboxylase, alpha-ketoacid carboxylase, and pyruvic decarboxylase. In anaerobic conditions, this enzyme is part of an alternative pathway for fermentation,known as Entner-Dourdoff pathway, which is characterized by the bypass of Acetyl-CoA formation, and determines an irreversible loss of a CO2 molecule, in order to produce acetaldehyde. Pyruvate decarboxylase starts this process by converting pyruvate into acetaldehyde and carbon dioxide. To do this, two thiamine pyrophosphate (TPP) and two magnesium ions are required as cofactors. This enzyme should not be mistaken for the unrelated enzyme pyruvate dehydrogenase, an oxidoreductase (EC 1.2.4.1), that catalyzes the oxidative decarboxylation of pyruvate to acetyl-CoA.
They are a class of enzymes that catalyse the conversion between alcohols and aldehydes or ketons, in order to decrease the toxicity of alcoholic products. Though, in the glycolytic process it is used in the opposite direction, by converting aldehydes into alcohols. All the reactions involved are reduction or oxidations, with the contribution of nicotinamide dinucleotide (NAD), as a cofactor. ADH2 (gene name adhB) catalyses the crucial step into ethanol conversion: acetaldehyde comes from the last steps of glycolysis and the bacteria converts it into an ethanol molecule in order to gain a NAD+, as a reducing power, when in anaerobic, or microaerobial environment. Structurally, the alcohol dehydrogenase family is composed by multimeric proteins, about 300 amino acids long (ADH2 of Z.mobilis is by 383 amino acids and 40,145 KDa weight). The ratio between isoforms of each monomer may vary. Moreover, each unit has two zinc binding domains, where a zinc ion is the core of the active site: it settles an hydrogen bond with NAD, helped by Cys-146, Cys-174, and His-67; while the lateral chains of Phe-319, Ala-317, His-51, Ile-269 and Val-292 bind aldehyde. Deprotonation of NAD is catalysed by Ser-48, which is deprotonated by His-51. When NAD+ loses its positive charge, it can reduce acetaldehyde to ethanol and become NADH. We selected Zymomonas mobilis as the source of the adhB transgene for implementing the conversion efficiency in the glucose-to-ethanol process, because it has been found that this microbiota follows a special glucose degradation pathway (Entner-Dourdoff pathway), that hass as only final byproducts, two ethanol molecules by each glucose, while two ATP molecules are produced. Moreover, Z.mobilis has another adh gene (adhA), which does not seem an isoform even if it accomplishes the same function. In addition, adhB seems more efficient in ethanol conversion than its homologue. SYSTEM OVERVIEWOur purpose is to build up a biological system to convert lactose into ethanol. We chose E. coli bacterium as the system’s chassis and we have planned to engineer an efficient lactose-ethanol conversion system using three main enzymes: beta-galactosidase, pyruvate decarboxylase and alcohol dehydrogenase II. The engineered gene network we want to build up and characterize quantitatively is shown in figure.
The full characterization of this network will allow to know the efficiency and the feasibility of the entire system in cheese whey valorisation, as well as the estimation of B.O.D.5/C.O.D. parameters before and after the treatment of the waste with our engineered system.
E. coli has a well known gene system to grow in a lactose-rich and glucose-poor environment, whose main enzyme is the beta-galactosidase, which performs the conversion of lactose in glucose and galactose. The latter is then metabolized by other enzymes and is converted in glucose too. Although E. coli already has this system in nature, the lactose metabolism may be improved in several ways:
In this project, we want to overexpress the native E. coli enzyme under the control of a glucose-independent lactose-inducible strong promoter. We hope that this system will be able to convert lactose in glucose rapidly and without glucose inhibition. The genetic parts which can perform these functions are shown and described below.
BBa_R0011 is an artificial hybrid promoter derived from the lambda phage Pλ repressible strong promoter. In this hybrid promoter sequence, the cI binding sites have been replaced with lacO1 binding sites, so lacI repressor can bind and repress transcription in this promoter. Transcription can be switched on by adding lactose or IPTG, which bind lacI and repress its activity. The main advantage of using this promoter instead of the native E. coli lac promoter (BBa_R0010) is that the native one has a CAP binding site. So, when glucose is present in the environment the transcription is inhibited, even if lactose is present in the medium. The behaviour of the native promoter does not fit our project specifications because we want to engineer a strain which can metabolize lactose until it is over, so we used R0011 hybrid promoter. During the summer, we used BBa_J23118 constitutive promoter from UC Berkeley promoter collection to produce constantly lacI regulator, so that the lac promoter is in the “off” state until lactose or IPTG are added to the culture. Anyway, other constitutive promoters can be used for lacI production, in order to optimize the expression of beta-gal in real processes. This inducible system will be built up, characterized and submitted to the Registry as a lactose/IPTG input -> PoPS output device, which can be generalized by assembling the desired protein generator downstream. Used BioBrick parts:
The gene which encodes for beta galactosidase in E. coli is called lacZ and it is present in the Registry as BBa_I732005. We used it in association with a strong RBS to build up a beta-galactosidase protein generator which can ensure an efficient overexpression of the enzyme (the protein generator was actually present in the Registry as BBa_I732019, but its sequence analysis gave bad results in 2008 Distribution, so we re-built it). As written above, beta-galactosidase performs the conversion of lactose in glucose and galactose; on the other hand, galactose is metabolized by the cell and converted in glucose through another pathway. So, the expression of this protein generator is the only needed step for the conversion of lactose in glucose, which is essential for the ethanol fermentation we plan to engineer in our project. In this artificial protein generator, lacZ gene can be replaced with any other beta-galactosidase genes taken from the genome of other organisms in order to compare their activity and to choose the most efficient one. Used BioBrick parts:
Future work Other ways to improve lactose metabolism in E. coli may be to:
In this project, two genes from the fermentative bacterium Zymomonas mobilis are used to build up an ethanol-producing operon in E. coli. Genes pdc and adhB, which encode for pyruvate decarboxylase and alcohol dehydrogenase respectively, will be assembled to engineer an ethanol producing system. DNA synthesis technology and the Registry of Standard Biological Parts will be used to optimize the characteristics of the operon, in particular:
The codon usage has been optimized for E. coli, through DNA de novo synthesis, in order to have a high efficiency translation of pdc and adhB genes. The ethanol yield and the metabolic burden will be calibrated using different PoPS inputs. This optimized operon can be considered as the final actuator for our project: it converts glucose, the intermediate product, in ethanol, which can be used as a biofuel directly or can be converted in different biofuels, e.g. biodiesel through a transesterification process. The final version of the actuator should be controlled by a constitutive promoter in order to ensure an efficient and continuous ethanol production without any additional cost for inducer molecules. However, the strength of the promoter has to be calibrated and the assembly of the operon with a high number of promoter BioBricks can be avoided using well characterized inducible promoters. These inducible systems can be used as user-controlled knobs for gene expression. In order to compare the strengths of different promoters, a standard measurement system has been used: the Relative Promoter Units (RPUs), proposed by Kelly J. et al. (2008). The characterization of these systems would significantly contribute to Synthetic Biology community, because it would provide well-characterized and re-usable parts to the Registry. In particular, we have focused our attention on IPTG, aTc and 3OC6HSL inducible systems. Used BioBrick parts:
Future work
The final part containing pdc and adhB II has to be controlled by the best promoter, i.e. the promoter with transcriptional strength that ensures a yield as close as possible to the theoretical value. We want to build up a collection of well characterized promoters both constitutive and inducible, to use to optimize the operon yield, as well as every other device. In order to characterize inducible system behaviour, an important part of our project will be dedicated to perform quantitative experiments of these constructs. The systems we want to use are
This device is based on the expression of tetR, a molecule which has the ability of inhibit the activity of ptet promoter. In presence of aTc, tetR is inactivated and ptet is free to express. We want to test different promoters to regulate the expression of the repressor molecule, so we plan to assemble several promoters of Anderson Promoters Collection.
This device gives PoPS as output and can be induced with 3OC6-HSL autoinducer molecule: it binds luxR protein (encoded by ), which is constitutively expressed by tetR promoter (). LuxR-HSL complex can work as a transcriptional activator for lux promoter ().
The hybrid lac promoter () has been designed taking the Plambda promoter () and substituting its cI () binding sites with two lacI binding sites. This promoter can be repressed by lacI (), which can be repressed by lactose or IPTG, providing a lactose/IPTG inducible system. Differently from wild type lac promoter, this part does not have any CAP binding sites, so its behaviour is glucose-independent.
|
